Bayard Powell to Leukemia, Lymphocytic, Chronic, B-Cell
This is a "connection" page, showing publications Bayard Powell has written about Leukemia, Lymphocytic, Chronic, B-Cell.
Connection Strength
0.418
-
Keung YK, Buss D, Pettenati M, Powell BL. CD5-negative chronic lymphocytic leukemia or monoclonal B-lymphocytosis of undetermined significance? Am J Hematol. 2002 Aug; 70(4):334.
Score: 0.208
-
High KP, Case D, Hurd D, Powell B, Lesser G, Falsey AR, Siegel R, Metzner-Sadurski J, Krauss JC, Chinnasami B, Sanders G, Rousey S, Shaw EG. A randomized, controlled trial of Panax quinquefolius extract (CVT-E002) to reduce respiratory infection in patients with chronic lymphocytic leukemia. J Support Oncol. 2012 Sep-Oct; 10(5):195-201.
Score: 0.100
-
Frankel AE, Fleming DR, Hall PD, Powell BL, Black JH, Leftwich C, Gartenhaus R. A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 1):3555-61.
Score: 0.056
-
Frankel AE, Fleming DR, Powell BL, Gartenhaus R. DAB389IL2 (ONTAK) fusion protein therapy of chronic lymphocytic leukaemia. Expert Opin Biol Ther. 2003 Feb; 3(1):179-86.
Score: 0.054